Post-Marketing Change Management Policy Analysis of Autologous CAR-T Therapy Products in China, the United States, and the European Union

Li Yingmeng, Shi Wenyu, Yao Dongning, Zhang Liying

Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (10) : 1200-1211.

PDF(1078 KB)
PDF(1078 KB)
Chinese Pharmaceutical Affairs ›› 2026, Vol. 40 ›› Issue (10) : 1200-1211. DOI: 10.16153/j.1002-7777.2025-12-0011
Supervision & Administration

Post-Marketing Change Management Policy Analysis of Autologous CAR-T Therapy Products in China, the United States, and the European Union

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 40(10): 1200-1211 https://doi.org/10.16153/j.1002-7777.2025-12-0011

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1078 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉